About This Fund
Earlybird Health Fund II is a venture capital fund managed by Earlybird Venture Capital. The fund will predominantly invest in European companies from the early development stage to advanced technologies nearing regulatory approval and commercialisation. The Fund aims to invest in companies across healthcare sectors including digital health, diagnostics, medical devices, R&D tools, and biopharma – delivering robust and positive patient outcomes, regardless of the technology applied. It also complies with the Article 8 Fund criteria, per the EU’s Sustainable Finance Disclosure Regulation (SFDR). The new Earlybird Health Fund received support from major institutional investors across Europe. Investors include: British Patient Capital or BARMER.